Georgina L. Ryland

2.4k total citations
30 papers, 1.2k citations indexed

About

Georgina L. Ryland is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Georgina L. Ryland has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Georgina L. Ryland's work include Cancer Genomics and Diagnostics (13 papers), Genomics and Rare Diseases (4 papers) and Acute Myeloid Leukemia Research (4 papers). Georgina L. Ryland is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Genomics and Rare Diseases (4 papers) and Acute Myeloid Leukemia Research (4 papers). Georgina L. Ryland collaborates with scholars based in Australia, United Kingdom and United States. Georgina L. Ryland's co-authors include Ian Campbell, Maria Doyle, Jason Li, Kylie L. Gorringe, Ella R. Thompson, Sally M. Hunter, Saman Halgamuge, Simone M. Rowley, Richard W. Tothill and Kaushalya Amarasinghe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Georgina L. Ryland

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgina L. Ryland Australia 17 561 501 351 311 274 30 1.2k
Johanna Tapper Finland 14 701 1.2× 353 0.7× 410 1.2× 339 1.1× 246 0.9× 22 1.4k
Samuli Hemmer Finland 10 694 1.2× 340 0.7× 473 1.3× 410 1.3× 312 1.1× 12 1.4k
Francesco Favero United States 8 679 1.2× 725 1.4× 178 0.5× 668 2.1× 229 0.8× 10 1.4k
Kimberley Howarth United Kingdom 15 631 1.1× 384 0.8× 275 0.8× 347 1.1× 486 1.8× 20 1.4k
Keisuke Kurose Japan 14 634 1.1× 310 0.6× 96 0.3× 312 1.0× 191 0.7× 30 1.0k
Olivier Caron France 23 1.0k 1.9× 657 1.3× 721 2.1× 842 2.7× 746 2.7× 72 2.4k
Michael Churchman United Kingdom 21 473 0.8× 223 0.4× 125 0.4× 409 1.3× 247 0.9× 45 1.1k
Agnieszka Dansonka‐Mieszkowska Poland 17 462 0.8× 240 0.5× 124 0.4× 162 0.5× 204 0.7× 32 1.0k
Sally M. Hunter Australia 14 413 0.7× 248 0.5× 151 0.4× 199 0.6× 154 0.6× 20 852
Arnaud Da Cruz Paula United States 21 290 0.5× 360 0.7× 66 0.2× 348 1.1× 303 1.1× 74 1.2k

Countries citing papers authored by Georgina L. Ryland

Since Specialization
Citations

This map shows the geographic impact of Georgina L. Ryland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgina L. Ryland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgina L. Ryland more than expected).

Fields of papers citing papers by Georgina L. Ryland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgina L. Ryland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgina L. Ryland. The network helps show where Georgina L. Ryland may publish in the future.

Co-authorship network of co-authors of Georgina L. Ryland

This figure shows the co-authorship network connecting the top 25 collaborators of Georgina L. Ryland. A scholar is included among the top collaborators of Georgina L. Ryland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgina L. Ryland. Georgina L. Ryland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidson, N., Teresa Sadras, Georgina L. Ryland, et al.. (2022). JAFFAL: detecting fusion genes with long-read transcriptome sequencing. Genome biology. 23(1). 10–10. 33 indexed citations
2.
Ryland, Georgina L., Michelle McBean, Eric Wong, et al.. (2021). T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection. Bone Marrow Transplantation. 56(10). 2582–2590. 2 indexed citations
3.
Keam, Simon P., Heloise M. Halse, Thu Quynh Nguyen, et al.. (2020). High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot. Journal for ImmunoTherapy of Cancer. 8(1). e000792–e000792. 51 indexed citations
4.
Blombery, Piers, Lucy C. Fox, Georgina L. Ryland, et al.. (2020). Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes. Haematologica. 106(1). 64–73. 11 indexed citations
5.
Markham, John, Georgina L. Ryland, Huei San Leong, et al.. (2019). CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencing. Scientific Reports. 9(1). 6426–6426. 19 indexed citations
6.
Williams, Scott, Simon P. Keam, Heloise M. Halse, et al.. (2019). Direct evidence of a clonal and tumor-directed T cell response to prostate cancer brachytherapy.. Journal of Clinical Oncology. 37(7_suppl). 22–22. 1 indexed citations
7.
Blombery, Piers, Kate Jones, Ken Doig, et al.. (2018). Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory. Archives of Pathology & Laboratory Medicine. 142(5). 606–612. 7 indexed citations
8.
Blombery, Piers, Ella R. Thompson, Georgina L. Ryland, et al.. (2018). Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma. Oncotarget. 9(90). 36126–36136. 57 indexed citations
9.
Doig, Kenneth, Jason Ellul, Andrew Fellowes, et al.. (2017). Canary: an atomic pipeline for clinical amplicon assays. BMC Bioinformatics. 18(1). 555–555. 2 indexed citations
10.
Ryland, Georgina L., Sally M. Hunter, Maria Doyle, et al.. (2015). Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Medicine. 7(1). 87–87. 109 indexed citations
11.
Hunter, Sally M., et al.. (2014). Genomic Aberrations of BRCA1-Mutated Fallopian Tube Carcinomas. American Journal Of Pathology. 184(6). 1871–1876. 1 indexed citations
12.
Li, Jason, Maria Doyle, Isaam Saeed, et al.. (2014). Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment. PLoS ONE. 9(4). e95217–e95217. 18 indexed citations
13.
Amarasinghe, Kaushalya, Jason Li, Sally M. Hunter, et al.. (2014). Inferring copy number and genotype in tumour exome data. BMC Genomics. 15(1). 732–732. 84 indexed citations
14.
Goode, David L., Sally M. Hunter, Maria Doyle, et al.. (2013). A simple consensus approach improves somatic mutation prediction accuracy. Genome Medicine. 5(9). 90–90. 23 indexed citations
15.
Ryland, Georgina L., Maria Doyle, Samantha E. Boyle, et al.. (2012). MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers. PLoS ONE. 7(4). e35805–e35805. 25 indexed citations
16.
Ryland, Georgina L., Sally M. Hunter, Maria Doyle, et al.. (2012). RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. The Journal of Pathology. 229(3). 469–476. 88 indexed citations
17.
Thompson, Ella R., Maria Doyle, Georgina L. Ryland, et al.. (2012). Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles. PLoS Genetics. 8(9). e1002894–e1002894. 147 indexed citations
18.
Li, Jason, Richard Lupat, Kaushalya Amarasinghe, et al.. (2012). CONTRA: copy number analysis for targeted resequencing. Bioinformatics. 28(10). 1307–1313. 248 indexed citations
19.
Ramakrishna, Manasa, et al.. (2011). Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer. BMC Cancer. 11(1). 173–173. 16 indexed citations
20.
Thompson, Ella R., Samantha E. Boyle, Julie K. Johnson, et al.. (2011). Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Human Mutation. 33(1). 95–99. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Tapper Breakdown of academic impact, for papers by Samuli Hemmer Breakdown of academic impact, for papers by Francesco Favero Breakdown of academic impact, for papers by Kimberley Howarth Breakdown of academic impact, for papers by Keisuke Kurose Breakdown of academic impact, for papers by Olivier Caron Breakdown of academic impact, for papers by Michael Churchman Breakdown of academic impact, for papers by Agnieszka Dansonka‐Mieszkowska Breakdown of academic impact, for papers by Sally M. Hunter Breakdown of academic impact, for papers by Arnaud Da Cruz Paula
Rankless by CCL
2026